SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-000278
Filing Date
2024-01-03
Accepted
2024-01-03 16:15:28
Documents
1
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 form4-01032024_040105.html 4  
1 form4-01032024_040105.xml 4 4134
  Complete submission text file 0001415889-24-000278.txt   5539
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XILIO THERAPEUTICS, INC. 828 WINTER STREET WALTHAM MA 02451
Business Address
Luptakova Katarina (Reporting) CIK: 0001991149 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 24506571